BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2004621)

  • 1. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
    Epilepsia; 1991; 32(2):168-73. PubMed ID: 2004621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
    Life Sci; 1992; 50(4):319-26. PubMed ID: 1732702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
    Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
    Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats.
    Dailey JW; Jobe PC
    Epilepsia; 1986; 27(6):665-70. PubMed ID: 2877867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat.
    Lasley SM
    Brain Res; 1991 Sep; 560(1-2):63-70. PubMed ID: 1684733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.
    Clough RW; Peterson BR; Steenbergen JL; Jobe PC; Eells JB; Browning RA; Mishra PK
    Epilepsy Res; 1998 Jan; 29(2):135-46. PubMed ID: 9477146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat.
    Jobe PC; Laird HE; Ko KH; Ray T; Dailey JW
    Epilepsia; 1982 Aug; 23(4):359-66. PubMed ID: 6284498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
    Merrill MA; Clough RW; Jobe PC; Browning RA
    Epilepsia; 2005 Sep; 46(9):1380-8. PubMed ID: 16146432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats.
    Seo DO; Shin CY; Ryu JR; Cheong JH; Choi CR; Dailey JW; Reith ME; Jobe PC; Ko KH
    Eur J Pharmacol; 2000 May; 396(2-3):53-8. PubMed ID: 10822056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat.
    Dailey JW; Reigel CE; Mishra PK; Jobe PC
    Epilepsy Res; 1989; 3(1):3-17. PubMed ID: 2563686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats.
    Jobe PC; Dailey JW; Reigel CE
    Life Sci; 1986 Sep; 39(9):775-82. PubMed ID: 3747729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetically epilepsy-prone rat (GEPR).
    Jobe PC; Mishra PK; Adams-Curtis LE; Deoskar VU; Ko KH; Browning RA; Dailey JW
    Ital J Neurol Sci; 1995; 16(1-2):91-9. PubMed ID: 7642359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic abnormalities in the genetically epilepsy-prone rat.
    Jobe PC; Mishra PK; Browning RA; Wang C; Adams-Curtis LE; Ko KH; Dailey JW
    Brain Res Bull; 1994; 35(5-6):493-504. PubMed ID: 7859107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in brain and pituitary beta-endorphin content in genetically epilepsy-prone rats.
    Carr JA; Carpenter AM; D'Souza MM; Elmore AR; Lovering AT; Reigel CE
    Epilepsy Res; 1998 Jul; 31(2):113-22. PubMed ID: 9714502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
    Mishra PK; Dailey JW; Reigel CE; Jobe PC
    Life Sci; 1988; 42(11):1131-7. PubMed ID: 3347143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine.
    Clough RW; Browning RA; Maring ML; Statnick MA; Wang C; Jobe PC
    J Neural Transplant Plast; 1994; 5(1):65-79. PubMed ID: 7819373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic activation of the amygdala differentially mimics the effects of audiogenic seizure kindling in two substrains of genetically epilepsy-prone rats.
    Raisinghani M; Feng HJ; Faingold CL
    Exp Neurol; 2003 Oct; 183(2):516-22. PubMed ID: 14552892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs.
    Reigel CE; Dailey JW; Jobe PC
    Life Sci; 1986 Sep; 39(9):763-74. PubMed ID: 3747727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of age on seizure susceptibility in genetically epilepsy-prone rats (GEPR-9s).
    Thompson JL; Carl FG; Holmes GL
    Epilepsia; 1991; 32(2):161-7. PubMed ID: 2004620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic terminal fields as determinants of seizure predisposition in GEPR-3s: a neuroanatomic assessment with intracerebral microinjections of 6-hydroxydopamine.
    Wang C; Mishra PK; Dailey JW; Jobe PC; Browning RA
    Epilepsy Res; 1994 May; 18(1):1-9. PubMed ID: 8088252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.